Document is current
Any future updates will be listed below
-
Authors
Haluck-Kangas, Ashley
Patel, Monal
Paudel, Bidur
Vaidyanathan, Aparajitha
Murmann, Andrea E.
Peter, Marcus E. http://orcid.org/0000-0003-3216-036X
-
Funding
Funding for this research was provided by:
Ovarian Cancer Research Fund Alliance (458788)
Lynn Sage Cancer Research Foundation
Friends of Prentice
The Lefkofsky Family Foundation
Chicago Biomedical Consortium (Accelerator Award)
National Cancer Institute (R35CA197450, U54CA151880)
National Institute of Allergy and Infectious Diseases (R21AI150910)
- License Information
-
More Information
Article History
Received: 22 September 2021
Accepted: 5 November 2021
First Online: 10 December 2021
Declarations
:
: Not applicable.
: Not applicable.
: M. Peter and A. Murmann are cofounders of NUAgo Therapeutics Inc. and inventors on US Patent: 6,696,547, nonprovisional patent applications U.S. Serial No. 62/821,776 and 62/821,782 and M. Peter, A. Murmann and M. Patel are inventors on nonprovisional patent application 15/900,392. All other authors report no disclosures.
